ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. AFIB, BRSH, SDCCQ, GMVDF, NMRD, UTRS, MOTS, VIVE, DRTSW, and ANZUWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors Acutus Medical Bruush Oral Care SmileDirectClub G Medical Innovations Nemaura Medical Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Acutus Medical (NASDAQ:AFIB) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Do insiders & institutionals have more ownership in AFIB or VRAYQ? 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 2.5% of ViewRay shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to AFIB or VRAYQ? In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score. Company Overall Sentiment Acutus Medical Neutral ViewRay Neutral Which has better earnings & valuation, AFIB or VRAYQ? Acutus Medical has higher earnings, but lower revenue than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.00-$81.66MN/AN/AViewRay$102.21M0.00-$107.33MN/AN/A Which has more volatility & risk, AFIB or VRAYQ? Acutus Medical has a beta of -0.57, indicating that its stock price is 157% less volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Is AFIB or VRAYQ more profitable? ViewRay has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. ViewRay's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% ViewRay N/A N/A N/A SummaryViewRay beats Acutus Medical on 5 of the 8 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$32.53M$5.70B$9.51BDividend YieldN/AN/A4.69%4.01%P/E RatioN/A2.8728.0720.05Price / SalesN/A195.12448.5799.42Price / CashN/A41.3636.2258.56Price / BookN/A2.038.665.87Net Income-$107.33M-$2.66M$3.25B$258.55M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300AFIBAcutus MedicalN/A$0.01+150.0%N/A-99.5%$66K$7.16M0.00340Gap UpBRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/A$0.00flatN/AN/A$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072NMRDNemaura Medical1.1529 of 5 starsN/AN/A-99.4%$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GIN/A$0.00-66.7%N/A-99.8%$1K$319K0.0030Gap DownHigh Trading VolumeVIVEViveve MedicalN/AN/AN/A-66.7%$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.27-2.1%N/A+6.4%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/AN/A$0.00N/A0.002 Related Companies and Tools Related Companies Acutus Medical Alternatives Bruush Oral Care Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Nemaura Medical Alternatives Minerva Surgical Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRAYQ Stock Alerts